Global Newsroom

CSL Extends Reach of Global Research Acceleration Initiative with Freshly Inked Partnerships to Fast-Track Research Programs

Bernadette Murdoch, an experienced Australian and global corporate affairs and communications leader across multiple industries, will join CSL and lead its global Reputation Management Center of Excellence (CoE).

MARBURG, GERMANY
The new facility, once fully open later this calendar year, will be CSL’s largest R&D site under one roof, with more than 500 team members working in a state-of-the-art facility offering access to promising scientific partners and talent.

CSL is on track to file for regulatory approvals at end of current fiscal year and will present full data set at an upcoming scientific congress

CSL advances its vision for a more sustainable future by setting new, tangible targets for carbon emissions reductions

Global biotech leader CSL today announced that all business units will be united as one family under the CSL global brand.

CSL continues to provide medicines to patients around the world.

Statement attributable to Greg Boss, Executive Vice President - Legal, and CSL Limited Group General Counsel.

CSL ranked fourth on the Health Industry list, from a total of more than 750 organisations nominated in all sectors across Australia and New Zealand.

CSL Plasma U.S. collection centers are preparing to undergo implementation of newly cleared Rika Plasma Donation System, with limited market release beginning in Colorado centers.

With 25,000 global employees, CSL is one of 500 Large Employers recognized across 25 industry sectors

CSL Behring AG Publishes Offer Prospectus On Public Tender Offer For All Publicly Held Shares Of Vifor Pharma Ltd.

Through the StartX partnership, CSL will access an ecosystem of early stage biotech, medtech and digital healthcare ventures, exploring opportunities to collaborate around disruptive technologies and build relationships with entrepreneurial founders.

CSL Reaffirms Commitment to Manufacture AstraZeneca COVID Vaccine into 2022